Arkema SA (OTCMKTS:ARKAY) Receives Consensus Rating of “Reduce” from Brokerages

Shares of Arkema SA (OTCMKTS:ARKAY) have been given an average recommendation of “Reduce” by the seven brokerages that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company.

A number of analysts recently commented on ARKAY shares. Barclays downgraded shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. Zacks Research downgraded Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Finally, The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a report on Tuesday, February 10th.

Arkema Price Performance

Arkema stock opened at $71.29 on Monday. The company has a market cap of $5.42 billion, a P/E ratio of 34.27, a price-to-earnings-growth ratio of 1.47 and a beta of 0.90. Arkema has a one year low of $56.28 and a one year high of $91.51. The business has a fifty day moving average of $64.51 and a two-hundred day moving average of $63.98. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.26 and a current ratio of 3.07.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.